** Aspen Aerogels Inc's shares down 5.5% to $20.17 in extended trading as co looks to raise equity ** Specialty chemicals maker commences 4.25 mln share offering for working capital, capex and other purposes
** Goldman Sachs and Morgan Stanley jt bookrunners ** ASPN last Weds closed up ~13% at $25.41 after co received $671 mln conditional loan commitment from U.S. DOE for construction of planned second aerogel manufacturing facility in Register, Georgia ** Co also forecast Q3 rev above consensus
** Stock on Mon fell 1.3% to $21.33, giving it market value of ~$1.6 bln based on ~77 mln shares outstanding, per LSEG
** Shares up 35% YTD and were trading around $7 a year ago
(Lance Tupper is a Reuters market analyst. The views expressed are his own) ((lance.tupper@thomsonreuters.com lance.tupper@tr.com 1-646-279-6380))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.